A medical technology SaaS business with no competitors coming into a period of major catalysts.
Once the phase two trials are complete, the company will be able to engage with the FDA. Once the FDA approves the treatment, which is hihgly likely as the results have been released as part of the open plan phase two study, the door opens for commercial discussions. There is no phase 3 required for medical technology, once phase 2 is complete that is it and phase 2 would have less than 90 patients to test.
- Forums
- ASX - By Stock
- TRI
- Ann: TrivarX Receives Firm Commitments to Raise $2.5 million
Ann: TrivarX Receives Firm Commitments to Raise $2.5 million, page-5
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TRI (ASX) to my watchlist
|
|||||
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $10.96M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 41500 | 2.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.5¢ | 199980 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 41500 | 0.023 |
5 | 676030 | 0.021 |
2 | 300000 | 0.020 |
2 | 1000000 | 0.019 |
3 | 1750000 | 0.018 |
Price($) | Vol. | No. |
---|---|---|
0.025 | 199980 | 1 |
0.026 | 455040 | 3 |
0.027 | 500000 | 1 |
0.028 | 160000 | 1 |
0.030 | 236823 | 2 |
Last trade - 16.12pm 27/08/2024 (20 minute delay) ? |
Featured News
TRI (ASX) Chart |
Day chart unavailable
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online